erythrosine has been researched along with Neoplasms in 95 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
Excerpt | Relevance | Reference |
---|---|---|
"Hydrogen-rich water has a significant protective effect on OGD/R-causing HT22 cell injury, and the mechanism may be related to the inhibition of autophagy." | 4.40 | Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19. ( , 2023) |
"As a result, cancer cells are more susceptible to death by any further rise in levels of these species." | 1.91 | Nanoparticles for combined photo- and chemo-dynamic therapy of cancer cells involving endogenous glutathione depletion. ( Biswas, L; Mittal, A; Roy, I; Verma, AK; Yadav, M, 2023) |
"Upon conjugation to ketone-labeled cancer cells via a pH-responsive hydrazone linkage, Alexa Fluor 488-hydrazide became internalized and entered endosomes/lysosomes where ketone-sugars can be released and recycled." | 1.72 | Recyclable cell-surface chemical tags for repetitive cancer targeting. ( Bhatta, R; Han, J; Li, H; Wang, H; Zhou, J, 2022) |
"Numerous human cancers, especially hypoxic solid tumors, express carbonic anhydrase IX (CAIX), a transmembrane protein with its catalytic domain located in the extracellular space." | 1.72 | Picomolar fluorescent probes for compound affinity determination to carbonic anhydrase IX expressed in live cancer cells. ( Baranauskienė, L; Becker, HM; Čapkauskaitė, E; Dubois, LJ; Dudutienė, V; Jachno, J; Juozapaitienė, V; Kačenauskaitė, L; Kazokaitė-Adomaitienė, J; Kopanchuk, S; Kvietkauskaitė, A; Matulienė, J; Matulis, D; Michailovienė, V; Mickevičiūtė, A; Paketurytė-Latvė, V; Petrauskas, V; Petrošiūtė, A; Rinken, A; Shubin, K; Sližienė, A; Smirnovienė, J; Stravinskienė, D; Veiksina, S; Yaromina, A; Zakšauskas, A; Zubrienė, A; Žvinys, G, 2022) |
"The immune system exerts a tight cancer surveillance to eradicate nascent and developing tumors." | 1.56 | Evaluation of NK cell cytotoxic activity against malignant cells by the calcein assay. ( González, S; López-Soto, A; Lorenzo-Herrero, S; Sordo-Bahamonde, C, 2020) |
"In A549 (Axl positive) cancer xenografts, the tumor uptake of h173-Cy5." | 1.40 | Axl-targeted cancer imaging with humanized antibody h173. ( Conti, PS; Gill, PS; Krasnoperov, V; Li, D; Li, Z; Liu, R; Liu, S; Park, R; Shan, H; Yu, H, 2014) |
"Polymersomes encapsulated with the anticancer drugs gemcitabine and doxorubicin showed significant cytotoxicity to these cells." | 1.40 | Multifunctional polymersomes for cytosolic delivery of gemcitabine and doxorubicin to cancer cells. ( Ambre, AH; Gange, KN; Haldar, MK; Katti, KS; Layek, B; Mallik, S; Meghnani, V; Nahire, R; Paul, S; Sarkar, K; Singh, J, 2014) |
"In Akt-hyperactive cancer, TopBP1 forms oligomers and represses E2F1-dependent apoptosis." | 1.40 | Targeting TopBP1 at a convergent point of multiple oncogenic pathways for cancer therapy. ( Chowdhury, P; Lin, FT; Lin, GE; Lin, WC; Liu, K; Song, Y, 2014) |
"The metastasis suppressor breast cancer metastasis suppressor 1 (BRMS1) upregulates GJIC and decreases phosphoinositide-3-kinase (PI3K) signaling." | 1.36 | Homotypic gap junctional communication associated with metastasis suppression increases with PKA activity and is unaffected by PI3K inhibition. ( Beck, BH; Bodenstine, TM; Cook, LM; Diers, AR; Ismail, A; Landar, A; Vaidya, KS; Welch, DR, 2010) |
"Montelukast was the most potent inhibitor (p<0." | 1.35 | Montelukast is a potent and durable inhibitor of multidrug resistance protein 2-mediated efflux of taxol and saquinavir. ( Chakravarty, G; Honer Zu Bentrup, K; Mondal, D; Roy, U, 2009) |
"The multicellular layers (MCL) of human cancer cells have been successfully used to study tissue pharmacokinetics of anticancer drugs." | 1.35 | Novel application of multicellular layers culture for in situ evaluation of cytotoxicity and penetration of paclitaxel. ( Al-Abd, AM; Kim, SY; Kuh, HJ; Kun, N; Lee, JH, 2008) |
"Further studies on fresh human tumors were conducted with a novel topoisomerase II inhibitor, NC-190." | 1.33 | Image analysis using the fluorochromasia assay to quantify tumor drug sensitivity. ( Gibbs, JF; Rustum, YM; Slocum, HK, 2005) |
" The aim of this study was to assess the systemic bioavailability of this rationally designed drug in 16 patients with advanced solid cancers." | 1.31 | Bioavailability study of oral and intravenous OGT 719, a novel nucleoside analogue with preferential activity in the liver. ( Brown, G; Carmichael, J; Clayton, KT; Eatock, MM; McLelland, HR; Moyses, C; O'Byrne, KJ; Sharma, RA; Steward, WP; Twelves, CJ, 2001) |
"The FFP response in cancer patients was the reverse of that in normal individuals, but an abnormal response was also obtained in some noncancer conditions, including the chronic inflammatory disorders--rheumatoid arthritis, cholecystitis, and diverticulitis--and in early pregnancy or pregnancy-induced hypertension." | 1.27 | Significance of lymphocyte fluorescence polarization changes after phytohemagglutinin stimulation in cancer and noncancer conditions. ( Nairn, RC; Nind, AP; Pihl, E; Rolland, JM, 1984) |
"The results using 469 human malignant tumors showed that the micro-organ culture assay can distinguish individual tumor chemosensitivity profiles with an overall success rate of 96%." | 1.27 | Individual human tumors in short-term micro-organ cultures: chemosensitivity testing by fluorescent cytoprinting. ( Cozzolino, JP; Dickinson, K; Rotman, B; Teplitz, C, 1988) |
"A cancer (hepatoma) cell strain is described in which the formation of junctional membrane channels is abnormally slow." | 1.26 | Intercellular communication and tissue growth: VII. A cancer cell strain with retarded formation of permeable membrane junction and reduced exchange of a 330-dalton molecule. ( Azarnia, R; Loewenstein, WR, 1976) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 41 (43.16) | 18.7374 |
1990's | 6 (6.32) | 18.2507 |
2000's | 20 (21.05) | 29.6817 |
2010's | 18 (18.95) | 24.3611 |
2020's | 10 (10.53) | 2.80 |
Authors | Studies |
---|---|
Sakamoto, T | 1 |
Fukui, Y | 1 |
Kondoh, Y | 1 |
Honda, K | 1 |
Shimizu, T | 1 |
Hara, T | 1 |
Hayashi, T | 1 |
Saitoh, Y | 1 |
Murakami, Y | 1 |
Inoue, JI | 1 |
Kaneko, S | 1 |
Osada, H | 1 |
Seiki, M | 1 |
Mu, X | 1 |
Jiang, X | 1 |
Zhang, Y | 2 |
Liu, X | 3 |
Zhang, S | 1 |
Wang, W | 2 |
Huang, Y | 2 |
Ma, P | 1 |
Song, D | 1 |
López, CL | 1 |
Brempelis, KJ | 1 |
Matthaei, JF | 1 |
Montgomery, KS | 1 |
Srinivasan, S | 1 |
Roy, D | 1 |
Huang, F | 1 |
Kreuser, SA | 1 |
Gardell, JL | 1 |
Blumenthal, I | 1 |
Chiefari, J | 1 |
Jensen, MC | 1 |
Crane, CA | 1 |
Stayton, PS | 1 |
Luo, Q | 1 |
Napoleon, JV | 1 |
Zhang, B | 1 |
Zheng, S | 1 |
Low, PS | 1 |
Bhatta, R | 1 |
Han, J | 1 |
Zhou, J | 1 |
Li, H | 2 |
Wang, H | 2 |
Matulienė, J | 1 |
Žvinys, G | 1 |
Petrauskas, V | 1 |
Kvietkauskaitė, A | 1 |
Zakšauskas, A | 1 |
Shubin, K | 1 |
Zubrienė, A | 1 |
Baranauskienė, L | 1 |
Kačenauskaitė, L | 1 |
Kopanchuk, S | 1 |
Veiksina, S | 1 |
Paketurytė-Latvė, V | 1 |
Smirnovienė, J | 1 |
Juozapaitienė, V | 1 |
Mickevičiūtė, A | 1 |
Michailovienė, V | 1 |
Jachno, J | 1 |
Stravinskienė, D | 1 |
Sližienė, A | 1 |
Petrošiūtė, A | 1 |
Becker, HM | 1 |
Kazokaitė-Adomaitienė, J | 1 |
Yaromina, A | 1 |
Čapkauskaitė, E | 1 |
Rinken, A | 1 |
Dudutienė, V | 1 |
Dubois, LJ | 1 |
Matulis, D | 1 |
Mittal, A | 1 |
Yadav, M | 1 |
Biswas, L | 1 |
Verma, AK | 1 |
Roy, I | 1 |
Wu, L | 1 |
Pan, M | 1 |
Chen, Y | 1 |
Huang, H | 1 |
Zhang, X | 1 |
Wang, F | 1 |
Zhou, X | 1 |
Lorenzo-Herrero, S | 1 |
Sordo-Bahamonde, C | 1 |
González, S | 1 |
López-Soto, A | 1 |
Mills, B | 1 |
Norberg, D | 1 |
Dhaliwal, K | 1 |
Akram, AR | 1 |
Bradley, M | 1 |
Megia-Fernandez, A | 1 |
Inoue, T | 1 |
Shimozato, O | 1 |
Matsuo, N | 1 |
Mori, Y | 1 |
Shinozaki, Y | 1 |
Lin, J | 1 |
Watanabe, T | 1 |
Takatori, A | 1 |
Koshikawa, N | 1 |
Ozaki, T | 1 |
Nagase, H | 1 |
Ma, X | 1 |
Shi, X | 1 |
Bai, S | 1 |
Zhang, J | 1 |
Hou, M | 1 |
Zhang, T | 1 |
Li, BS | 1 |
Xue, P | 1 |
Kang, Y | 1 |
Xu, Z | 1 |
Rubio, L | 1 |
Marcos, R | 1 |
Hernández, A | 1 |
Remacle, AG | 1 |
Shiryaev, SA | 1 |
Golubkov, VS | 1 |
Freskos, JN | 1 |
Brown, MA | 1 |
Karwa, AS | 1 |
Naik, AD | 1 |
Howard, CP | 1 |
Sympson, CJ | 1 |
Strongin, AY | 1 |
Li, D | 1 |
Liu, S | 1 |
Liu, R | 1 |
Park, R | 1 |
Yu, H | 1 |
Krasnoperov, V | 1 |
Gill, PS | 1 |
Li, Z | 1 |
Shan, H | 1 |
Conti, PS | 1 |
Meyer, C | 1 |
Berg, K | 1 |
Eydeler-Haeder, K | 1 |
Lorenzen, I | 1 |
Grötzinger, J | 1 |
Rose-John, S | 1 |
Hahn, U | 1 |
Nahire, R | 1 |
Haldar, MK | 1 |
Paul, S | 1 |
Ambre, AH | 1 |
Meghnani, V | 1 |
Layek, B | 1 |
Katti, KS | 1 |
Gange, KN | 1 |
Singh, J | 1 |
Sarkar, K | 1 |
Mallik, S | 1 |
Yao, X | 1 |
Zhang, R | 1 |
Ouyang, L | 1 |
Jiang, R | 1 |
Song, C | 1 |
Zhang, G | 1 |
Fan, Q | 1 |
Wang, L | 1 |
Huang, W | 1 |
Chowdhury, P | 1 |
Lin, GE | 1 |
Liu, K | 1 |
Song, Y | 1 |
Lin, FT | 1 |
Lin, WC | 1 |
Chen, G | 1 |
Zhu, JY | 1 |
Zhang, ZL | 1 |
Zhang, W | 1 |
Ren, JG | 1 |
Wu, M | 1 |
Hong, ZY | 1 |
Lv, C | 1 |
Pang, DW | 1 |
Zhao, YF | 1 |
Hu, Z | 1 |
Sim, Y | 1 |
Kon, OL | 1 |
Ng, WH | 1 |
Ribeiro, AJ | 1 |
Ramos, MJ | 1 |
Fernandes, PA | 1 |
Ganguly, R | 1 |
Xing, B | 1 |
García, F | 1 |
Yeow, EK | 1 |
Zhai, G | 1 |
Wu, J | 1 |
Xiang, G | 1 |
Mao, W | 1 |
Yu, B | 1 |
Piao, L | 1 |
Lee, LJ | 1 |
Lee, RJ | 1 |
Kitamura, N | 1 |
Murata, S | 1 |
Ueki, T | 1 |
Mekata, E | 1 |
Reilly, RT | 1 |
Jaffee, EM | 1 |
Tani, T | 1 |
Tu, Z | 1 |
Volk, M | 1 |
Shah, K | 1 |
Clerkin, K | 1 |
Liang, JF | 1 |
Partridge, J | 1 |
Flaherty, P | 1 |
Roy, U | 1 |
Chakravarty, G | 1 |
Honer Zu Bentrup, K | 1 |
Mondal, D | 1 |
Zhao, P | 1 |
Liang, X | 1 |
Gong, X | 1 |
Song, T | 1 |
Niu, R | 1 |
Chang, J | 1 |
Hoff, A | 1 |
Bagû, AC | 1 |
André, T | 1 |
Roth, G | 1 |
Wiesmüller, KH | 1 |
Gückel, B | 1 |
Brock, R | 1 |
Bodenstine, TM | 1 |
Vaidya, KS | 1 |
Ismail, A | 1 |
Beck, BH | 1 |
Cook, LM | 1 |
Diers, AR | 1 |
Landar, A | 1 |
Welch, DR | 1 |
Wei, Y | 1 |
Song, J | 1 |
Chen, Q | 1 |
Cheng, D | 1 |
Gong, F | 1 |
Miao, X | 1 |
Shuai, X | 1 |
Kumari, S | 1 |
Chowdhury, J | 1 |
Mishra, AK | 1 |
Chandna, S | 1 |
Saluja, D | 1 |
Chopra, M | 1 |
Wang, J | 1 |
Xing, D | 2 |
He, Y | 2 |
Hu, X | 1 |
Gottfried, E | 1 |
Krieg, R | 1 |
Eichelberg, C | 1 |
Andreesen, R | 1 |
Mackensen, A | 1 |
Krause, SW | 1 |
CHEVALLIER, A | 1 |
BURG, C | 1 |
LAUSECKER, C | 1 |
KING, ES | 1 |
HUGHES, PE | 1 |
LOUIS, CJ | 3 |
GOTHAM, JE | 1 |
GILROY, J | 1 |
MEYER, JS | 1 |
CHOLEWA, L | 1 |
GORSKI, L | 1 |
ORTIZBERROCAL, J | 1 |
DERENZI, G | 1 |
LAMARCHE, V | 1 |
D AMBRA, L | 1 |
VIGI, F | 1 |
WITTMAN, I | 1 |
ASZODI, Z | 1 |
PAPP, L | 1 |
POTTS, AM | 1 |
EASTY, GC | 1 |
DANIEL BEK, KV | 1 |
WAGNER, DE | 1 |
BAUM, S | 1 |
NARITSYN, IZ | 1 |
BRILMAYER, C | 1 |
KOHLER, A | 1 |
MACK, A | 1 |
STORDEUR, K | 1 |
Teng, MW | 1 |
Kershaw, MH | 1 |
Moeller, M | 1 |
Smyth, MJ | 1 |
Darcy, PK | 1 |
Guo, L | 1 |
Roeske, RW | 1 |
Antony, AC | 1 |
Jayaram, HN | 1 |
Bian, H | 1 |
Fournier, P | 1 |
Moormann, R | 1 |
Peeters, B | 1 |
Schirrmacher, V | 1 |
Gibbs, JF | 1 |
Rustum, YM | 1 |
Slocum, HK | 1 |
Takahashi, E | 1 |
Kuranaga, N | 1 |
Satoh, K | 1 |
Habu, Y | 1 |
Shinomiya, N | 1 |
Asano, T | 1 |
Seki, S | 1 |
Hayakawa, M | 1 |
Bracher, M | 1 |
Gould, HJ | 1 |
Sutton, BJ | 1 |
Dombrowicz, D | 1 |
Karagiannis, SN | 1 |
Schwab, R | 1 |
Micsik, T | 1 |
Szokolóczi, O | 1 |
Schafer, E | 1 |
Tihanyi, B | 1 |
Tihanyi, T | 1 |
Kupcsulik, P | 1 |
Diófalvi, K | 1 |
Mersich, T | 1 |
Besznyak, I | 1 |
Zarand, A | 1 |
Mihalik, R | 1 |
Sarkadi, B | 2 |
Kéri, G | 1 |
Pap, A | 1 |
Jakab, F | 1 |
Kopper, L | 1 |
Petak, I | 1 |
Urano, Y | 1 |
Kamiya, M | 1 |
Nagano, T | 1 |
Kobayashi, H | 1 |
Al-Abd, AM | 1 |
Lee, JH | 1 |
Kim, SY | 1 |
Kun, N | 1 |
Kuh, HJ | 1 |
Balding, P | 1 |
Light, PA | 1 |
Preece, AW | 1 |
Benes, J | 2 |
Musgrove, E | 1 |
Rugg, C | 1 |
Taylor, I | 1 |
Hedley, D | 1 |
Rolland, JM | 2 |
Nairn, RC | 2 |
Nind, AP | 1 |
Pihl, E | 1 |
Glass, W | 1 |
Jenssen, HL | 1 |
Mix, E | 1 |
Friedrich, A | 1 |
Hocking, GR | 1 |
Pritchard, JA | 1 |
Sutherland, WH | 1 |
Siddall, JE | 1 |
Bater, AJ | 1 |
Kerby, IJ | 1 |
Deeley, TJ | 1 |
Wyllie, RG | 1 |
Cohen, FJ | 1 |
Manganaro, J | 1 |
Bezozo, RC | 1 |
Blumenthal, R | 1 |
Ralston, E | 1 |
Dragsten, P | 1 |
Leserman, LD | 1 |
Weinstein, JN | 1 |
Strauchen, JA | 1 |
Gaetjens, E | 1 |
Pertschuk, LP | 1 |
Boutorine, AS | 1 |
Venyaminova, AG | 1 |
Repkova, MN | 1 |
Sergueyeva, ZA | 1 |
Pyshnyï, DV | 1 |
Gruber, M | 1 |
Schodin, BA | 1 |
Wilson, ER | 1 |
Kranz, DM | 1 |
King, MA | 1 |
Radicchi-Mastroianni, MA | 1 |
Zhu, XD | 1 |
Wei, S | 1 |
Guo, XW | 1 |
Nakanishi, A | 1 |
Guan, L | 1 |
Kane, RR | 1 |
Kasamatsu, H | 1 |
Hawthorne, MF | 1 |
Szakács, G | 1 |
Jakab, K | 1 |
Antal, F | 1 |
Smeltzer, CC | 1 |
Cannon, MJ | 1 |
Pinson, PR | 1 |
Munger, JD | 1 |
West, FG | 1 |
Grissom, CB | 1 |
Sharma, RA | 1 |
Eatock, MM | 1 |
Twelves, CJ | 1 |
Brown, G | 1 |
McLelland, HR | 1 |
Clayton, KT | 1 |
O'Byrne, KJ | 1 |
Moyses, C | 1 |
Carmichael, J | 1 |
Steward, WP | 1 |
van Mierlo, GJ | 1 |
den Boer, AT | 1 |
Medema, JP | 1 |
van der Voort, EI | 1 |
Fransen, MF | 1 |
Offringa, R | 1 |
Melief, CJ | 1 |
Toes, RE | 1 |
Yan, G | 1 |
Ueda, Ki | 1 |
Azarnia, R | 2 |
Loewenstein, WR | 3 |
Blakeslee, D | 1 |
Sinangil, F | 1 |
Harada, S | 1 |
Purtilo, DT | 1 |
Volsky, DJ | 1 |
Rotman, B | 1 |
Teplitz, C | 1 |
Dickinson, K | 1 |
Cozzolino, JP | 1 |
Dzbanovskiĭ, NN | 1 |
Polsachev, VI | 1 |
Rakhimov, AT | 1 |
Rubin, LB | 1 |
Plüss, HJ | 1 |
Johnson, WW | 1 |
Wallach, DF | 1 |
Knufermann, H | 1 |
Wunderlich, F | 1 |
Nagel, GA | 1 |
Schaefer, DT | 1 |
Baldwin, L | 1 |
Matsuoka, T | 1 |
Saisho, T | 1 |
Kimura, M | 1 |
Konaka, K | 1 |
5 reviews available for erythrosine and Neoplasms
Article | Year |
---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
[RADIOACTIVE ISOTOPES IN THE NEUROLOGICAL DIAGNOSIS].
Topics: Arsenic; Bismuth; Boron; Brain Neoplasms; Copper; Fluoresceins; Fluorine; Humans; Iodine Isotopes; M | 1963 |
[In-vivo cancer fluorescence imaging with novel precisely-designed fluorescence probes].
Topics: Animals; beta-Galactosidase; Diagnostic Imaging; Fluoresceins; Fluorescent Dyes; Humans; Molecular P | 2007 |
Diagnostics of multidrug resistance in cancer.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Biologic | 1998 |
Junctional intercellular communication and the control of growth.
Topics: Animals; Breast Neoplasms; Calcium; Carcinoma, Hepatocellular; Cell Communication; Cell Count; Cell | 1979 |
1 trial available for erythrosine and Neoplasms
Article | Year |
---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
90 other studies available for erythrosine and Neoplasms
Article | Year |
---|---|
Pharmacological inhibition of Mint3 attenuates tumour growth, metastasis, and endotoxic shock.
Topics: Adaptor Proteins, Signal Transducing; Carcinogenesis; Cell Line, Tumor; Fluoresceins; Humans; Hypoxi | 2021 |
Sensitive ratiometric fluorescence probe based on chitosan carbon dots and calcein for Alkaline phosphatase detection and bioimaging in cancer cells.
Topics: Alkaline Phosphatase; Carbon; Chitosan; Fluoresceins; Fluorescent Dyes; Humans; Neoplasms; Quantum D | 2021 |
Arming Immune Cell Therapeutics with Polymeric Prodrugs.
Topics: Fluoresceins; Humans; Ligands; Neoplasms; Polymers; Prodrugs | 2022 |
Targeted Rejuvenation of Exhausted Chimeric Antigen Receptor T Cells Regresses Refractory Solid Tumors.
Topics: Fluoresceins; Humans; Neoplasms; Receptors, Chimeric Antigen; Rejuvenation; T-Lymphocytes; Toll-Like | 2022 |
Recyclable cell-surface chemical tags for repetitive cancer targeting.
Topics: Cell Membrane; Click Chemistry; Fluoresceins; Humans; Hydrazines; Ketones; Neoplasms; Polysaccharide | 2022 |
Picomolar fluorescent probes for compound affinity determination to carbonic anhydrase IX expressed in live cancer cells.
Topics: Antigens, Neoplasm; Carbonic Anhydrase IX; Carbonic Anhydrases; Cell Line, Tumor; Fluoresceins; Fluo | 2022 |
Nanoparticles for combined photo- and chemo-dynamic therapy of cancer cells involving endogenous glutathione depletion.
Topics: Cell Line, Tumor; Fluoresceins; Glutathione; Humans; Hydrogen Peroxide; Nanoparticles; Neoplasms; Ph | 2023 |
The construction of DNAzyme-based logic gates for amplified microRNA detection and cancer recognition.
Topics: Alkanesulfonates; Azo Compounds; Biomarkers, Tumor; Computers, Molecular; DNA, Catalytic; Endodeoxyr | 2019 |
Evaluation of NK cell cytotoxic activity against malignant cells by the calcein assay.
Topics: CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cytotoxicity Tests, Immunologic; Cytotoxicity, Immunol | 2020 |
A matrix metalloproteinase activation probe for painting human tumours.
Topics: Carbocyanines; Fluoresceins; Fluorescent Dyes; Humans; Matrix Metalloproteinases; Microscopy, Fluore | 2020 |
Hydrophobic structure of hairpin ten-ring pyrrole-imidazole polyamides enhances tumor tissue accumulation/retention in vivo.
Topics: Animals; Cell Line, Tumor; Cell Nucleus; Female; Fluoresceins; Fluorescence; Fluorescent Dyes; Human | 2018 |
Water-soluble fluorescent unimolecular micelles: ultra-small size, tunable fluorescence emission from the visible to NIR region and enhanced biocompatibility for in vitro and in vivo bioimaging.
Topics: Animals; beta-Cyclodextrins; Biocompatible Materials; Carbocyanines; Cell Line, Tumor; Cytoskeleton; | 2018 |
Nanoceria acts as antioxidant in tumoral and transformed cells.
Topics: Animals; Antioxidants; Apoptosis; Cell Line, Transformed; Cell Line, Tumor; Cell Survival; Cerium; C | 2018 |
Non-destructive and selective imaging of the functionally active, pro-invasive membrane type-1 matrix metalloproteinase (MT1-MMP) enzyme in cancer cells.
Topics: Animals; Binding, Competitive; Blotting, Western; Cell Line; Cell Line, Tumor; Fluoresceins; Fluores | 2013 |
Axl-targeted cancer imaging with humanized antibody h173.
Topics: Animals; Antibodies, Monoclonal, Humanized; Axl Receptor Tyrosine Kinase; Carbocyanines; Cell Line, | 2014 |
Stabilized Interleukin-6 receptor binding RNA aptamers.
Topics: Aptamers, Nucleotide; Fluoresceins; Humans; Neoplasms; Protein Binding; Receptors, Interleukin-6; RN | 2014 |
Multifunctional polymersomes for cytosolic delivery of gemcitabine and doxorubicin to cancer cells.
Topics: Acoustics; Calorimetry, Differential Scanning; Cell Line, Tumor; Cell Survival; Chromatography, Gel; | 2014 |
Cationic conjugated polymer/fluoresceinamine-hyaluronan complex for sensitive fluorescence detection of CD44 and tumor-targeted cell imaging.
Topics: Cations; Cell Line, Tumor; Drug Delivery Systems; Fluoresceins; Fluorescence Resonance Energy Transf | 2014 |
Targeting TopBP1 at a convergent point of multiple oncogenic pathways for cancer therapy.
Topics: Animals; Apoptosis; Breast Neoplasms; Carrier Proteins; DNA-Binding Proteins; E2F1 Transcription Fac | 2014 |
Transformation of cell-derived microparticles into quantum-dot-labeled nanovectors for antitumor siRNA delivery.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biotinylation; Cell Line, Tumor; Cell Proliferation; Cell | 2015 |
Unique Triphenylphosphonium Derivatives for Enhanced Mitochondrial Uptake and Photodynamic Therapy.
Topics: Cell Line; Drug Carriers; Fluoresceins; Halogenation; HeLa Cells; Humans; Hydrophobic and Hydrophili | 2017 |
Preparation, characterization and pharmacokinetics of folate receptor-targeted liposomes for docetaxel delivery.
Topics: Animals; Antineoplastic Agents; Carrier Proteins; Cell Line, Tumor; Cell Survival; Docetaxel; Drug D | 2009 |
OX40 costimulation can abrogate Foxp3+ regulatory T cell-mediated suppression of antitumor immunity.
Topics: Adoptive Transfer; Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Line, Tumor | 2009 |
Constructing bioactive peptides with pH-dependent activities.
Topics: Amino Acid Sequence; Animals; Arginine; Cell Death; Cell Line; Fluoresceins; Histidine; Humans; Hydr | 2009 |
An in vitro FluoroBlok tumor invasion assay.
Topics: Animals; Collagen; Drug Combinations; Extracellular Matrix; Fluoresceins; Fluorescent Dyes; Humans; | 2009 |
Montelukast is a potent and durable inhibitor of multidrug resistance protein 2-mediated efflux of taxol and saquinavir.
Topics: Acetates; Animals; Anti-Asthmatic Agents; Antineoplastic Agents, Phytogenic; Biological Transport; C | 2009 |
Folate-PEG coated cationic modified chitosan--cholesterol liposomes for tumor-targeted drug delivery.
Topics: Cations; Cell Line, Tumor; Chitosan; Cholesterol; Drug Delivery Systems; Flow Cytometry; Fluorescein | 2010 |
Peptide microarrays for the profiling of cytotoxic T-lymphocyte activity using minimum numbers of cells.
Topics: Cell Count; Cell Line, Tumor; Cytotoxicity Tests, Immunologic; Epitope Mapping; Fluoresceins; Fluore | 2010 |
Homotypic gap junctional communication associated with metastasis suppression increases with PKA activity and is unaffected by PI3K inhibition.
Topics: Androstadienes; Cell Communication; Cell Line, Tumor; Cell Membrane; Chromones; Connexin 43; Cyclic | 2010 |
In vivo detection of chemiluminescence to monitor photodynamic threshold dose for tumor treatment.
Topics: Animals; Cell Line, Tumor; Dihematoporphyrin Ether; Female; Fluoresceins; Imidazoles; Light; Lumines | 2011 |
Design of multifunctional micelle for tumor-targeted intracellular drug release and fluorescent imaging.
Topics: Animals; Antineoplastic Agents; Drug Carriers; Fluoresceins; Fluorescence Resonance Energy Transfer; | 2012 |
Synthesis and evaluation of a fluorescent non-peptidic cholecystokinin-B/gastrin receptor specific antagonist for cancer cell imaging.
Topics: Animals; Benzodiazepinones; Cells; Chromatography, High Pressure Liquid; Fluoresceins; Fluorescent D | 2012 |
Experimental study on photodynamic diagnosis of cancer mediated by chemiluminescence probe.
Topics: Animals; Diagnostic Techniques and Procedures; Disease Models, Animal; Female; Fluoresceins; Hematop | 2002 |
Characterization of cells prepared by dendritic cell-tumor cell fusion.
Topics: Antigens, CD; B7-1 Antigen; B7-2 Antigen; CD83 Antigen; Cell Fusion; Cell Survival; Coculture Techni | 2002 |
[Distribution of labelled diiodofluorescein in normal tissues and in neoformations].
Topics: Fluoresceins; Neoplasms | 1953 |
The species non-specificity of globulins in the globulin-fluorescein staining of tissues.
Topics: Fluoresceins; Globulins; Neoplasms; Staining and Labeling | 1958 |
The significance of the cell type in the fluorescein-globulin staining of tissues.
Topics: Coloring Agents; Fluoresceins; Globulins; Humans; Neoplasms; Staining and Labeling | 1958 |
Studies of cerebral circulation time in man. 1. Normal values and alterations with cerebral vascular disease and tumour in arm-to-retina circulation times.
Topics: Arm; Axillary Vein; Blood Circulation Time; Cerebrovascular Circulation; Cerebrovascular Disorders; | 1962 |
[Delayed sodium fluoresceinate excretion in patients with malignant tumors].
Topics: Fluoresceins; Humans; Neoplasms; Sodium | 1962 |
[FIXATION OF RADIOACTIVE TRACERS IN RAT CHLOROMYELOMA STUDIES IN VIVO].
Topics: Fibrinogen; Fluoresceins; Iodine Isotopes; Leukemia; Neoplasms; Neoplasms, Experimental; Povidone; R | 1963 |
[CURRENT PRACTICE IN THE TREATMENT OF TUMORS WITH INTRA-ARTERIAL INJECTIONS OF ANTINEOPLASTIC SUBSTANCES].
Topics: Aminopterin; Antineoplastic Agents; Carcinoma; Chemotherapy, Cancer, Regional Perfusion; Chlorambuci | 1963 |
[RECENT USE OF DYE SOLUTIONS IN DIAGNOSIS. I. CHROMOLAPAROSCOPY. (PRELIMINARY REPORT)].
Topics: Acridines; Chlortetracycline; Clinical Laboratory Techniques; Congo Red; Dogs; Endoscopy; Fluorescei | 1964 |
TRACER STUDIES ON A TRANSPLANTABLE HAMSTER MELANOMA.
Topics: Animals; Chlorpromazine; Cricetinae; Eye Neoplasms; Fluoresceins; Idoxuridine; Iodine Isotopes; Mela | 1964 |
THE UPTAKE OF FLUORESCENT LABELLED PROTEINS BY NORMAL AND TUMOUR TISSUES IN VIVO.
Topics: Animals; Carcinoma, Hepatocellular; Carcinosarcoma; Cattle; Coloring Agents; Cricetinae; Diphtheria | 1964 |
[ON THE PRACTICAL VALUE OF THE MACROLUMINESCENCE ANALYSIS IN CANCER SURGERY].
Topics: Breast Neoplasms; Fluoresceins; Humans; Intestinal Neoplasms; Neoplasms; Stomach Neoplasms; Surgical | 1964 |
PRELIMINARY ARTERIOGRAPHY IN HEPATIC ARTERY INFUSIONS FOR CANCER.
Topics: Angiography; Catheterization; Chemotherapy, Cancer, Regional Perfusion; Fluoresceins; Hepatic Artery | 1965 |
[DIAGNOSIS OF CANCER AGAINST THE BACKGROUND OF GASTRIC CANCER BY MEANS OF SECONDARY FLUORESCENCE].
Topics: Fluoresceins; Fluorescence; Humans; Neoplasms; Stomach Neoplasms; Stomach Ulcer | 1965 |
[Affinity of certain dyes for healthy and neoplastic tissue proved by quantitative tissue extractions].
Topics: Coloring Agents; Fluoresceins; Humans; Neoplasms; Quinacrine; Tissue Extracts | 1955 |
Immunotherapy of cancer using systemically delivered gene-modified human T lymphocytes.
Topics: Animals; Carcinoma; Cell Proliferation; Colonic Neoplasms; Cytokines; Fluoresceins; Humans; Immunoth | 2004 |
Pteroyl-gamma-glutamate-cysteine synthesis and its application in folate receptor-mediated cancer cell targeting using folate-tethered liposomes.
Topics: Caco-2 Cells; Carrier Proteins; Chromatography, High Pressure Liquid; Cysteine; Doxorubicin; Fluores | 2004 |
Selective gene transfer in vitro to tumor cells via recombinant Newcastle disease virus.
Topics: Animals; Cell Line, Tumor; CHO Cells; Cricetinae; Cricetulus; Flow Cytometry; Fluoresceins; Gene Tra | 2005 |
Image analysis using the fluorochromasia assay to quantify tumor drug sensitivity.
Topics: 1,2-Dimethylhydrazine; Adenocarcinoma; Animals; Antineoplastic Agents; Biopsy; Cell Survival; Coloni | 2005 |
Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells.
Topics: Antineoplastic Agents; CD56 Antigen; Cytokines; Cytotoxicity, Immunologic; Fluoresceins; Histocompat | 2007 |
Three-colour flow cytometric method to measure antibody-dependent tumour cell killing by cytotoxicity and phagocytosis.
Topics: Antibodies, Monoclonal; Antibodies, Neoplasm; Antibody-Dependent Cell Cytotoxicity; Antigens, Neopla | 2007 |
Functional evaluation of multidrug resistance transporter activity in surgical samples of solid tumors.
Topics: Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Antigens, Surface; ATP Binding Cassette Transpo | 2007 |
Novel application of multicellular layers culture for in situ evaluation of cytotoxicity and penetration of paclitaxel.
Topics: Antineoplastic Agents, Phytogenic; Cell Proliferation; Cell Survival; Culture Techniques; Drug Evalu | 2008 |
Response of human lymphocytes to PHA and tumour-associated antigens as detected by fluorescence polarization.
Topics: Adult; Aged; Antigens, Neoplasm; Blood Sedimentation; Fluoresceins; Fluorescence Polarization; Human | 1980 |
[Clinical significance of polarizing luminescence in the study of changes in the cytoplasm of lymphocytes--SCM test].
Topics: Fluoresceins; Fluorescence Polarization; Humans; Lymphocyte Activation; Myelin Basic Protein; Neopla | 1984 |
Transferrin receptor expression during exponential and plateau phase growth of human tumour cells in culture.
Topics: Apoproteins; Cell Cycle; Cell Division; Cells, Cultured; Fluorescein-5-isothiocyanate; Fluoresceins; | 1984 |
Significance of lymphocyte fluorescence polarization changes after phytohemagglutinin stimulation in cancer and noncancer conditions.
Topics: Cyclic AMP; Cyclic GMP; Female; Fluorescein; Fluoresceins; Fluorescence Polarization; Humans; In Vit | 1984 |
Flow cytometric measurements of phagocytosis. I. A methodical and comparative study.
Topics: Erythrocytes; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluoresceins; Fluorescent Dyes; | 1984 |
Fluorescent lymphocyte probes for cancer detection.
Topics: 1-Naphthylamine; Acridine Orange; Fluorescein; Fluoresceins; Fluorescence Polarization; Humans; Lymp | 1983 |
Fluorescent probes for the detection of malignant disease.
Topics: 1-Naphthylamine; Carcinoma; Cell Separation; Female; Flow Cytometry; Fluorescein; Fluoresceins; Huma | 1983 |
Fluorescein-concanavalin A conjugates distinguish between normal and malignant human cells: a preliminary report.
Topics: Breast Neoplasms; Concanavalin A; Female; Fluorescein-5-isothiocyanate; Fluoresceins; Fluorescent An | 1981 |
Identification of involved tissue during surgical treatment of doxorubicin-induced extravasation necrosis.
Topics: Aged; Debridement; Doxorubicin; Female; Fluoresceins; Humans; Middle Aged; Necrosis; Neoplasms; Skin | 1983 |
[The binding of fluorescein derivatives to proteins and the study of intracellular hydrolysis of fluorescein diacetate in lymphocytes].
Topics: Fluoresceins; Humans; Lymphocyte Activation; Lymphocytes; Neoplasms; Protein Binding; Serum Albumin | 1983 |
Lipid vesicle-cell interactions: analysis of a model for transfer of contents from adsorbed vesicles to cells.
Topics: Adsorption; Animals; Cell Membrane; Endocytosis; Fluoresceins; Lipid Bilayers; Lymphocytes; Mathemat | 1982 |
Fluoresceinated lectins as probe for cell surface changes associated with lymphocyte transformation.
Topics: Carbohydrate Metabolism; Cell Line; Cell Membrane; Fluoresceins; Humans; Lectins; Lymphocyte Activat | 1982 |
Synthesis of fluorescein labelled steroid hormone-albumin conjugates for the fluorescent histochemical detection of hormone receptors.
Topics: Animals; Cattle; Fluoresceins; Histocytochemistry; Hormones; Humans; Neoplasms; Receptors, Steroid; | 1980 |
Effect of derivatization of ribophosphate backbone and terminal ribophosphate groups in oligoribonucleotides on their stability and interaction with eukaryotic cells.
Topics: Animals; Base Sequence; Cholesterol; Chromatography, High Pressure Liquid; Elapid Venoms; Electropho | 1994 |
Efficient tumor cell lysis mediated by a bispecific single chain antibody expressed in Escherichia coli.
Topics: Amino Acid Sequence; Animals; Antibodies, Bispecific; Base Sequence; Cytotoxicity, Immunologic; Esch | 1994 |
Use of four-colour flow cytometry to evaluate conjugate formation between human peripheral blood mononuclear cells and tumour target cells.
Topics: Azides; Cells, Cultured; Cytotoxicity, Immunologic; Enzyme Inhibitors; Flow Cytometry; Fluoresceins; | 1996 |
Imaging objects in tissuelike media with optical tagging and the diffuse photon differential transmittance.
Topics: Contrast Media; Diagnostic Imaging; Fluoresceins; Fluorescent Dyes; Humans; Neoplasms; Phantoms, Ima | 1997 |
Toward a cancer therapy with boron-rich oligomeric phosphate diesters that target the cell nucleus.
Topics: Biological Transport; Boron Compounds; Boron Neutron Capture Therapy; Cell Compartmentation; Cell Nu | 1999 |
Synthesis and characterization of fluorescent cobalamin (CobalaFluor) derivatives for imaging.
Topics: Boron Compounds; Fluoresceins; Fluorescent Dyes; Humans; Indicators and Reagents; Molecular Conforma | 2001 |
Bioavailability study of oral and intravenous OGT 719, a novel nucleoside analogue with preferential activity in the liver.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Area Under Curve; Biological Availability; | 2001 |
CD40 stimulation leads to effective therapy of CD40(-) tumors through induction of strong systemic cytotoxic T lymphocyte immunity.
Topics: Animals; CD40 Antigens; Coloring Agents; Epitopes; Flow Cytometry; Fluoresceins; Lymph Nodes; Male; | 2002 |
FCLA chemiluminescence from sonodynamic action in vitro and in vivo.
Topics: Fluoresceins; Free Radical Scavengers; Humans; Imidazoles; Luminescent Measurements; Neoplasms; Phot | 2002 |
Intercellular communication and tissue growth: VII. A cancer cell strain with retarded formation of permeable membrane junction and reduced exchange of a 330-dalton molecule.
Topics: Carcinoma, Hepatocellular; Cell Line; Cell Movement; Electrophysiology; Fluoresceins; Intercellular | 1976 |
Mitogen-induced changes in the fluorescence polarization of fluorescein in normal human lymphocytes: a membrane event?
Topics: Antibodies; Cell Membrane Permeability; Cytoplasm; Fluoresceins; Fluorescence Polarization; Humans; | 1979 |
Host cell range of adult T-cell leukemia virus. I. Viral infectivity and binding to various cells as detected by flow cytometry.
Topics: Animals; Callitrichinae; Cell Line; Deltaretrovirus; Erythrocytes; Fibroblasts; Flow Cytometry; Fluo | 1985 |
Individual human tumors in short-term micro-organ cultures: chemosensitivity testing by fluorescent cytoprinting.
Topics: Antineoplastic Agents; Cell Survival; Fluorescein; Fluoresceins; Humans; Microscopy, Fluorescence; N | 1988 |
[Sodium fluorescein-sensitized fluorescent diagnosis of malignant neoplasms].
Topics: Fluorescein; Fluoresceins; Humans; Neoplasms; Spectrometry, Fluorescence; Stomach Neoplasms | 1986 |
Parallel correction of cancerous growth and of a genetic defect of cell-to-cell communication.
Topics: Animals; Cell Division; Cell Fusion; Cell Line; Clone Cells; Epithelial Cells; Fibroblasts; Fluoresc | 1973 |
[Immunohistochemical studies on myosin in malignant tumors of childhood].
Topics: Age Factors; Animals; Autopsy; Biopsy; Child; Fibrosarcoma; Fluoresceins; Fluorescent Antibody Techn | 1968 |
Membrane aspects of neoplasia.
Topics: Animals; Antigens; B-Lymphocytes; Binding Sites; Cell Membrane; Cell Transformation, Neoplastic; Cel | 1973 |
Intra-arterial infusion for head and neck cancers.
Topics: Aged; Antineoplastic Agents; Brachiocephalic Trunk; Carcinoma, Squamous Cell; Carotid Arteries; Cath | 1973 |
[Immunosuppression: a paraneoplastic syndrome].
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Bronchial Neoplasms; Culture Techniques; Cyclophosphamide; | 1971 |
The photography of fluorescein-dye fluorescence in surgery.
Topics: Antineoplastic Agents; Blood Vessels; Catheterization; Chemotherapy, Cancer, Regional Perfusion; Flu | 1970 |
[Experimental studies on the affinity of flumejodin to tumor tissue].
Topics: Animals; Fluoresceins; Fluorescence; Iodine; Mice; Neoplasms; Neoplasms, Experimental; Organometalli | 1970 |